Articles About Galena BioPharma
February 19, 2014
ISIS Pharmaceuticals and Alnylam Pharmaceuticals have both experienced a sharp run-up as RNA-based therapeutics have re-emerged over the past couple of years.
February 03, 2014
These two stocks have have significant potential in their respective niches, and investors should take note.
January 17, 2014
Galena Pharmaceuticals stock has jumped 50 percent year-to-date. Jim Cramer advises watching the stock in future.
January 15, 2014
With a slew of catalysts coming later this year and a stock market that doesn’t appear to be slowing, investors may be in store for one heck of a run.